Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.
about
Differential Bone Loss in Mouse Models of Colon Cancer Cachexia.Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling PathwaysThe MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia.A Chinese herbal formula, Jian-Pi-Yi-Shen decoction, improves muscle atrophy via regulating mitochondrial quality control process in 5/6 nephrectomised rats.Understanding tumor anabolism and patient catabolism in cancer-associated cachexiaWhat Can be Learned from the Time Course of Changes in Low-Frequency Stimulated Muscle?Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.Dihydroartemisinin inhibits EMT induced by platinum-based drugs via Akt-Snail pathway.Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review.An analysis of the types of recently published research in the field of cachexia.Oxaliplatin induces muscle loss and muscle-specific molecular changes in MICE.A novel herbal formula, SGE, induces endoplasmic reticulum stress-mediated cancer cell death and alleviates cachexia symptoms induced by colon-26 adenocarcinoma.Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ-Induced Diabetic Mice.Anti-cachectic effect of Antrodia cinnamomea extract in lung tumor-bearing mice under chemotherapy.Chemotherapy-induced muscle wasting: an update.Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patientsDropping in on lipid droplets: insights into cellular stress and cancer
P2860
Q36260536-42BF22C7-E017-46B9-AAA6-804BF092BAD1Q37350003-3B9D17EB-7157-4DFF-A183-68C36077314AQ37590551-FF226A07-78C2-4BB1-B0B5-B0EACAB0F6E7Q38611121-B8D39D28-B484-40BD-9786-96039918CD3FQ39339489-14DF1935-D876-414D-937B-30EA735919EEQ42332564-46EB8BBA-9744-4756-99C2-6862D75CBE5BQ42376081-3FB89C1C-E1E1-4BCA-969F-2538020C7C90Q45219853-8D38AEE0-0656-49F4-B2DF-ABEACE0376F5Q47142435-4E52139E-19CE-447F-9C87-1125D6E88758Q47282365-65969229-BF84-471D-81DB-2F4A7F8930B0Q47568983-9B07503F-5AE1-411F-8C62-A8A18970DE5DQ47841514-3C1BD454-3EFC-426A-BAA9-F23692B723CBQ52584343-ABB2D4EA-2604-4577-81D7-C61E3837E87EQ55266104-11322584-C18A-458A-ACF1-BA564D0FCE1BQ55346140-EA53D915-6B9B-4EA8-BA28-D6D7AAB6EF72Q55483337-24AE3A29-B433-47C4-B4D5-FAC705090870Q57167639-7B5C55E4-A30D-440B-B9EA-32D5E75E4241Q57629429-85126A36-08A9-485C-BC72-04D9BF0D3770
P2860
Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy-related cachexia ...... ation of ERK1/2 and p38 MAPKs.
@en
Chemotherapy-related cachexia ...... ation of ERK1/2 and p38 MAPKs.
@nl
type
label
Chemotherapy-related cachexia ...... ation of ERK1/2 and p38 MAPKs.
@en
Chemotherapy-related cachexia ...... ation of ERK1/2 and p38 MAPKs.
@nl
prefLabel
Chemotherapy-related cachexia ...... ation of ERK1/2 and p38 MAPKs.
@en
Chemotherapy-related cachexia ...... ation of ERK1/2 and p38 MAPKs.
@nl
P2093
P2860
P356
P1433
P1476
Chemotherapy-related cachexia ...... ation of ERK1/2 and p38 MAPKs.
@en
P2093
David L Waning
Hongyu Gao
Rafael Barreto
Yunlong Liu
P2860
P304
43442-43460
P356
10.18632/ONCOTARGET.9779
P407
P577
2016-06-02T00:00:00Z